These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 36107387)
1. CPLX2 Regulates Ferroptosis and Apoptosis Through NRF2 Pathway in Human Hepatocellular Carcinoma Cells. Li H; Zhao J; Zhong XL; Xu PY; Du LJ; Fang P; Tan LJ; Li MJ; Zhang CF; Cao TS Appl Biochem Biotechnol; 2023 Jan; 195(1):597-609. PubMed ID: 36107387 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of MCF2L Promoted the Ferroptosis of Hepatocellular Carcinoma Cells through PI3K/mTOR Pathway in a RhoA/Rac1 Dependent Manner. Huang SC; Chen YM; Hu YY; Shi YJ; Xiao QW; Li Z; Kang JL; Zhou Q; Shen G; Jia HY Dis Markers; 2022; 2022():6138941. PubMed ID: 36330204 [TBL] [Abstract][Full Text] [Related]
3. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis. Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990 [TBL] [Abstract][Full Text] [Related]
4. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib. Yang C; Lu T; Liu M; Yuan X; Li D; Zhang J; Zhou L; Xu M Phytomedicine; 2023 Mar; 111():154668. PubMed ID: 36657316 [TBL] [Abstract][Full Text] [Related]
5. DDX5 deficiency drives non-canonical NF-κB activation and NRF2 expression, influencing sorafenib response and hepatocellular carcinoma progression. Li Z; Kim W; Utturkar S; Yan B; Lanman NA; Elzey BD; Kazemian M; Yeo Y; Andrisani O Cell Death Dis; 2024 Aug; 15(8):583. PubMed ID: 39122708 [TBL] [Abstract][Full Text] [Related]
6. Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2. Elkateb AS; Nofal S; Ali SA; Atya HB Inflammation; 2023 Aug; 46(4):1493-1511. PubMed ID: 37171695 [TBL] [Abstract][Full Text] [Related]
7. IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma. Lu Z; Yang H; Shao Y; Sun W; Jiang Y; Li J Biochem Biophys Res Commun; 2022 Oct; 627():103-110. PubMed ID: 36030651 [TBL] [Abstract][Full Text] [Related]
8. MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway. Liu X; Zhang F; Fan Y; Qiu C; Wang K Int Immunopharmacol; 2024 Dec; 142(Pt A):113107. PubMed ID: 39276458 [TBL] [Abstract][Full Text] [Related]
9. Benja-ummarit induces ferroptosis with cell ballooning feature through ROS and iron-dependent pathway in hepatocellular carcinoma. Sandech N; Yang MC; Juntranggoor P; Rukthong P; Gorelkin P; Savin N; Timoshenko R; Vaneev A; Erofeev A; Wichaiyo S; Pradidarcheep W; Maiuthed A J Ethnopharmacol; 2024 Dec; 335():118672. PubMed ID: 39127118 [TBL] [Abstract][Full Text] [Related]
10. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis. Zhang Y; Tan Y; Liu S; Yin H; Duan J; Fan L; Zhao X; Jiang B Toxicol Mech Methods; 2023 Jan; 33(1):47-55. PubMed ID: 35592903 [TBL] [Abstract][Full Text] [Related]
11. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis. Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597 [TBL] [Abstract][Full Text] [Related]
12. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Iseda N; Itoh S; Toshida K; Tomiyama T; Morinaga A; Shimokawa M; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Yoshizumi T; Mori M Cancer Sci; 2022 Jul; 113(7):2272-2287. PubMed ID: 35466502 [TBL] [Abstract][Full Text] [Related]
13. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma. Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J Front Oncol; 2021; 11():657723. PubMed ID: 34485112 [TBL] [Abstract][Full Text] [Related]
14. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells. Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082 [TBL] [Abstract][Full Text] [Related]
15. Protocadherin 20 promotes ferroptosis by suppressing the expression of Sirtuin 1 and promoting the acetylation of nuclear factor erythroid 2-related factor 2 in hepatocellular carcinoma. Jun L; Chen W; Han L; Yanmin L; Qinglei Z; Pengfei Z Int J Biochem Cell Biol; 2023 Mar; 156():106363. PubMed ID: 36641129 [TBL] [Abstract][Full Text] [Related]
16. Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway. Liu X; Liu T; Zhou Z; Bian K; Qiu C; Zhang F Biochem Biophys Res Commun; 2024 Nov; 734():150762. PubMed ID: 39353360 [TBL] [Abstract][Full Text] [Related]
17. SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Xu FL; Wu XH; Chen C; Wang K; Huang LY; Xia J; Liu Y; Shan XF; Tang N Cell Death Dis; 2023 Jan; 14(1):22. PubMed ID: 36635256 [TBL] [Abstract][Full Text] [Related]
18. SPARC regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma. Hua HW; Jiang HS; Jia L; Jia YP; Yao YL; Chen YW; Jiang F; Lu DQ; Zhou Q; Jiang MW; Ding G Cancer Biomark; 2021; 32(4):425-433. PubMed ID: 33843664 [TBL] [Abstract][Full Text] [Related]
19. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma. Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952 [TBL] [Abstract][Full Text] [Related]
20. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]